All Stories

  1. CRP and a biomarker of type I collagen degradation, C1M, can differentiate anti-inflammatory treatment response in ankylosing spondylitis
  2. Synovitis biomarkers:ex vivocharacterization of three biomarkers for identification of inflammatory osteoarthritis
  3. AB0086 PTH Stimulates Cartilage Formation in Low Turnover Patients – a Possible Systemic Anabolic Treatment for OA?:
  4. THU0090 C1M – A Biomarker of Disease Activity and Structural Progression in Rheumatoid Arthritis?
  5. SAT0045 The Activation of the Synovial Membrane Results in Release of Tissue Specific Biomarkers, Which in Turn can Act as Soluble Disease Activity Measures in Rheumatoid Arthritis
  6. Biological relevance of citrullinations: diagnostic, prognostic and therapeutic options
  7. SAT0419 Mmp-Dependent Tissue-Inflammation Predicts the Risk of Osteoarhritis-Progression after Five Years
  8. SAT0332 Connective Tissue Degradation by Matrix Metalloproteinases (C1M) is Predictive of Radiographic Progression in Ankylosing Spondylitis Preferentially in Patients Who Smoke
  9. Biomarkers of cartilage and surrounding joint tissue
  10. Synovitis, pain and serological biomarkers
  11. Association between biochemical cartilage markers and clinical symptoms in patients with hip osteoarthritis: cohort study with two-year follow-up
  12. Towards personalized health care in OA? identification of osteoarthritis (OA) patients into four phenotypic classes depending on their level of cartilage degradation and connective tissue inflammation
  13. Identification and characterisation of osteoarthritis patients with inflammation derived tissue turnover
  14. FRI0084 Structural progressors in rheumatoid arthritis identified by serology - identification of the patients in most need of intensive treatment
  15. SAT0317 Identification of Osteoarthritis Patients with Chronic Tissue Inflammation Whom may Benefit from Anti-Inflammatory Treatment
  16. Identification of the patients who respond safely and optimally to intervention with biologics; lesson learned from rheumatoid arthritis
  17. Segregation of OA patients into different treatment groups based on their level of systemic and tissue-specific inflammation
  18. Circulating levels of MMP-mediated connective tissue destruction is predictive of structural progression in patients with inflammatory arthritis
  19. Serological identification of fast progressors of structural damage with rheumatoid arthritis
  20. Matrix Metalloproteinase-dependent turnover of cartilage, synovial membrane, and connective tissue is elevated in rats with collagen induced arthritis